In the scheme of things, eyes receive little attention during the
perimenopausal and menopausal years. However, as Dr. Handwerger
illustrates for us, conditions arise during these years that can
significantly affect vision and quality of life. — Beverly
Vaughn, MD, Medical Coordinator, Menopause and You Program
Dry eye syndrome is a common occurrence in menopause and aging. It is
important to be able to understand the symptoms and treatment options
for this condition. Dry eye syndrome, if untreated, can have serious
effects on one of the most important aspects of a woman’s overall
health, her vision. With proper treatment, most women will be able to
enjoy optimal vision with little or no discomfort.
What is Dry Eye Syndrome?
Dry eye syndrome is caused by eyelid inflammation, lacrimal gland
dysfunction, medications and possibly changes in sex hormones due to
menopause or hormone replacement therapy (HRT).
The tear film is very important to maintaining healthy eyes. The
lacrimal gland, the goblet cells and the meibomian glands all produce a
different component of the tear film. The lacrimal gland is located in
the upper eyelid and is the key organ in tear production. The goblet
cells are located in the conjunctiva, which is the white part of the
eye. The meibomian glands are located throughout the eyelids. Tears
drain through the punctum, a small hole in the upper and lower eyelid,
to the nose. This is why a person's nose drains (runs) when he or she
Without an adequate tear film, dry eye syndrome can occur. This syndrome
can cause discomfort as well as damage to the eye and loss of vision.
Dry eye syndrome may result from one or more of the following factors:
inadequate tear production, increased tear evaporation and poor-quality
tears. Typical symptoms of dry eye syndrome include eye pain,
foreign-body sensation, burning, blurred vision, light sensitivity and
tearing. These symptoms can occur in varying degrees. Some people may
experience mild eye irritation and others can experience severe eye pain
and disruption of their lives. Dry eye syndrome occurs more commonly in
women, especially postmenopausal women.
Dry eye syndrome is diagnosed by clinical history and physical
examination of the eyes and eyelids. A slit lamp examination is
performed. A slit lamp is a microscope that allows the ophthalmologist
to look in detail at the eye. For patients with dry eye syndrome the
slit lamp examination may show a tear lake that appears to be less than
normal or tears that may evaporate more rapidly than normal. The cornea
or the conjunctiva may “stain” with fluorescein dye or Rose Bengal dye.
Also, a Schirmer’s test can be performed by placing diagnostic paper
strips in the corner of the eyelid for five minutes to measure the
amount of tears produced. Clinical findings, in combination with
symptoms of burning, stinging, grittiness, light sensitivity or eye
pain, confirm the diagnosis. Patients may notice increased tearing,
which may seem counterintuitive to someone experiencing dry eye
syndrome. A reflex pathway occurs in which the eye reacts to dryness to
create a high volume of low-quality tears.
The cause and severity of dry eye syndrome determine the basis for
treatment. There are several causes:
Inadequate production of tears
Irritating substances contained in the tear film
Rapid evaporation of tears
Inflammation of the lacrimal gland
If the tear production is inadequate or if the tear film contains
irritating substances, artificial tears may be used to increase the
lubrication of the eye. These will help protect the eye and relieve
discomfort. Also, a prescription medication called Restasis® may
increase the quantity and quality of tears produced. Restasis® is an
ophthalmic emulsion that contains cyclosporine in a very low
If the tears evaporate too quickly, the oil component of the tears may
need to be increased. This can be accomplished by using warm compresses
and medications to help the oil glands in the eyelid release their oily
secretions into the tear film. Artificial tears may be helpful as well.
The lacrimal gland is the key organ in tear production. Dry eye syndrome
can result from inflammation in the lacrimal gland. This occurs in peri-
and postmenopausal women, in Sjögren's syndrome and from aging.
Restasis® targets the inflammation in the lacrimal gland directly to
increase tear production and improve tear quality. This medication may
also improve the tear component made by the goblet cells in the
conjunctiva. Restasis® is particularly beneficial in the treatment of
dry eye in postmenopausal women and in the treatment of Sjögren's
Tears drain through the punctum through the lacrimal system to the nose.
Sometimes placing a small plug in the punctum can relieve the symptoms
of dry eye syndrome. This technique is similar to placing a stopper in
the bathtub. With a plug in place the tears will stay in the eye longer
and protect the eye with more lubrication. This is an office procedure,
which only takes a few minutes and is relatively painless. Punctal plugs
are microscopic and are barely visible to the eye.
Effect of Hormones
Dry eye syndrome occurs more frequently in postmenopausal women. The
levels of certain sex hormones, such as prolactin, testosterone and
estradiol, may affect the tear production. Androgen deficiency may be a
factor in the cause of evaporative dry eye syndrome in women. Therefore,
the effect of HRT has been studied. Several studies have shown that HRT
may alleviate postmenopausal dry eye by increasing the density of goblet
cells and tear film secretion. Subsequently, the Women’s Health Study of
25,665 postmenopausal women provided information about the use of HRT
and dry eye syndrome. This study revealed that women who use HRT,
particularly estrogen alone, are at an increased risk of dry eye
syndrome. Therefore, the relationship between sex hormones and dry eye
syndrome is unclear.
Preserving Eye Health
Recognizing the signs and symptoms of dry eye syndrome is an important
step in maintaining good vision. Early diagnosis and proper treatment by
an ophthalmologist can help women achieve optimal eye health and improve
their quality of life.
This article is part of the Menopause and Youlibrary,
a web-based program sponsored by Women’s Health Source.
It is intended as an information resource providing guidelines for
women. As always, check with your own health care practitioner with your
specific concerns and questions.
To speak with our nurse counselor, call 1.888.876.8764 or email firstname.lastname@example.org.
Membership on the medical staff of Main Line Hospitals does not
constitute an employment or agency relationship.
Connect with MLH
Women's Health Source
Women's Health Source
240 North Radnor Chester Road
Radnor, PA 19087
For more information, call 1.866.CALL.MLH.